BioatlaInc Historical Income Statement
BCAB Stock | USD 2.18 0.07 3.32% |
Historical analysis of BioatlaInc income statement accounts such as Interest Income of 6 M, Depreciation And Amortization of 1.4 M or Selling General Administrative of 24.7 K can show how well BioatlaInc performed in making a profits. Evaluating BioatlaInc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BioatlaInc's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining BioatlaInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BioatlaInc is a good buy for the upcoming year.
BioatlaInc |
About BioatlaInc Income Statement Analysis
BioatlaInc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BioatlaInc shareholders. The income statement also shows BioatlaInc investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
BioatlaInc Income Statement Chart
BioatlaInc Income Statement is one of the three primary financial statements used for reporting BioatlaInc's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of BioatlaInc revenue and expense. BioatlaInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, BioatlaInc's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6 M, whereas Interest Expense is projected to grow to (1.4 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BioatlaInc. It is also known as BioatlaInc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from BioatlaInc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BioatlaInc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioatlaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.At present, BioatlaInc's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6 M, whereas Interest Expense is projected to grow to (1.4 M).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.7M | 1.7M | 1.2M | 1.4M | Interest Income | 350K | 1.6M | 5.7M | 6.0M |
BioatlaInc income statement Correlations
Click cells to compare fundamentals
BioatlaInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioatlaInc income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Net Interest Income | (1.5M) | (1.3M) | 347K | 1.6M | 5.7M | 6.0M | |
Interest Income | 128K | 100K | 350K | 1.6M | 5.7M | 6.0M | |
Depreciation And Amortization | 966K | 1.1M | 1.7M | 1.7M | 1.2M | 1.4M | |
Interest Expense | 1.6M | 1.4M | 3K | (1.7M) | (1.5M) | (1.4M) | |
Selling General Administrative | 7.5M | 10.6M | 38.4M | 28.8M | 26.0K | 24.7K | |
Gross Profit | 5.2M | 409.1K | (1.1M) | (1.2M) | (1.2M) | (1.2M) | |
Other Operating Expenses | 33.5M | 30.5M | 96.7M | 108.1M | 129.7M | 80.2M | |
Operating Income | (28.3M) | (30.1M) | (96.4M) | (108.1M) | (129.7M) | (123.2M) | |
Net Income From Continuing Ops | (29.9M) | (35.9M) | (95.4M) | (106.5M) | (124.1M) | (117.9M) | |
Ebit | (28.3M) | (30.1M) | (96.4M) | (108.1M) | (129.7M) | (123.2M) | |
Research Development | 25.9M | 19.9M | 58.3M | 79.3M | 103.7M | 57.5M | |
Ebitda | (27.3M) | (29.0M) | (94.8M) | (106.5M) | (128.5M) | (122.0M) | |
Total Operating Expenses | 33.5M | 30.5M | 96.7M | 108.1M | 128.5M | 80.0M | |
Reconciled Depreciation | 860K | 1.0M | 1.3M | 1.2M | 1.2M | 1.2M | |
Income Before Tax | (29.9M) | (35.9M) | (95.4M) | (106.5M) | (123.5M) | (117.3M) | |
Total Other Income Expense Net | (1.6M) | (5.8M) | 1.0M | 1.7M | 6.2M | 6.5M | |
Net Income Applicable To Common Shares | (28.7M) | (26.9M) | (95.4M) | (106.5M) | (95.8M) | (91.0M) | |
Net Income | (31.4M) | (37.2M) | (95.4M) | (105.3M) | (123.5M) | (117.3M) | |
Income Tax Expense | 1.5M | 1.4M | 4K | (1.2M) | (1.1M) | (1.0M) |
Pair Trading with BioatlaInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioatlaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioatlaInc will appreciate offsetting losses from the drop in the long position's value.Moving together with BioatlaInc Stock
0.64 | MRK | Merck Company Earnings Call This Week | PairCorr |
Moving against BioatlaInc Stock
0.65 | GNTA | Genenta Science SpA Report 24th of April 2024 | PairCorr |
0.48 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
The ability to find closely correlated positions to BioatlaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioatlaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioatlaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioatlaInc to buy it.
The correlation of BioatlaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioatlaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioatlaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioatlaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioatlaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.Note that the BioatlaInc information on this page should be used as a complementary analysis to other BioatlaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for BioatlaInc Stock analysis
When running BioatlaInc's price analysis, check to measure BioatlaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioatlaInc is operating at the current time. Most of BioatlaInc's value examination focuses on studying past and present price action to predict the probability of BioatlaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioatlaInc's price. Additionally, you may evaluate how the addition of BioatlaInc to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is BioatlaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioatlaInc. If investors know BioatlaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioatlaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.58) | Quarterly Revenue Growth 0.316 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of BioatlaInc is measured differently than its book value, which is the value of BioatlaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BioatlaInc's value that differs from its market value or its book value, called intrinsic value, which is BioatlaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioatlaInc's market value can be influenced by many factors that don't directly affect BioatlaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioatlaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioatlaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioatlaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.